Anatomical and cellular localization of melatonin MT1 and MT2 receptors in the adult rat brain

Journal of Pineal Research

Volumn 58, Issue 4, 2015, Pages 397-417

  Lacoste, Baptiste ^a   Angeloni, Debora ^b   Dominguez Lopez, Sergio ^a,c   Calderoni, Sara ^d   Mauro, Alessandro ^d,e   Fraschini, Franco ^f   Descarries, Laurent ^c   Gobbi, Gabriella ^a  

^a MCGILL UNIVERSITY   (Canada)

^b SCUOLA SUPERIORE SANT ANNA   (Italy)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

Author keywords

brain; immunohistochemistry; melatonin receptors; neuroanatomy; rat

Indexed keywords

MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR;

ADULT; AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; BASAL GANGLION; BRAIN; BRAIN CORTEX; BRAIN TISSUE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DENDRITE; DENTATE GYRUS; DIENCEPHALON; DORSAL RAPHE NUCLEUS; EPITHALAMUS; FOREBRAIN; HABENULA; HIPPOCAMPAL CA3 REGION; HYPOPHYSIS; HYPOPHYSIS INTERMEDIATE LOBE; HYPOPHYSIS PARS TUBERALIS; IMMUNOGOLD LABELING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFERIOR COLLICULUS; MALE; MESENCEPHALON; NERVE CELL MEMBRANE; NONHUMAN; NUCLEUS ACCUMBENS; OLFACTORY BULB; OLFACTORY NERVOUS SYSTEM; PERIAQUEDUCTAL GRAY MATTER; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; RETROSPLENIAL CORTEX; SEPTUM PELLUCIDUM; SUBSTANTIA NIGRA; SUBSTANTIA NIGRA PARS COMPACTA; SUBSTANTIA NIGRA PARS RETICULATA; SUPERIOR COLLICULUS; SUPRACHIASMATIC NUCLEUS; SUPRAOPTIC NUCLEUS; TELENCEPHALON; THALAMUS; THALAMUS RETICULAR NUCLEUS; ANATOMY AND HISTOLOGY; ANIMAL; METABOLISM; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BRAIN; IMMUNOHISTOCHEMISTRY; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, MELATONIN, MT1; RECEPTOR, MELATONIN, MT2;

EID: 84926484822     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12224     Document Type: Article

References (76)

1. Reiter RJ, Tan DX, Kim SJ, et al. Delivery of pineal melatonin to the brain and SCN: role of canaliculi, cerebrospinal fluid, tanycytes and Virchow-Robin perivascular spaces. Brain Struct Funct 2014; 219: 1873-1887.
2. Comai S, Gobbi G,. Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology. J Psychiatry Neurosci 2014; 39: 6-21.
3. Galano A, Tan DX, Reiter RJ,. On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK. J Pineal Res 2013; 54: 245-257.
4. Zhang HM, Zhang Y,. Melatonin: a well-documented antioxidant with conditional pro-oxidant actions. J Pineal Res 2014; 57: 131-146.
5. Mauriz JL, Collado PS, Veneroso C, et al. A review of the molecular aspects of melatonin's anti-inflammatory actions: recent insights and new perspectives. J Pineal Res 2013; 54: 1-14.
6. Dubocovich ML, Markowska M,. Functional MT1 and MT2 melatonin receptors in mammals. Endocrine 2005; 27: 101-110.
7. Morgan PJ, Williams LM,. Central melatonin receptors: implications for a mode of action. Experientia 1989; 45: 955-965.
8. Rosales-Corral SA, Acuna-Castroviejo D, Coto-Montes A, et al. Alzheimer's disease: pathological mechanisms and the beneficial role of melatonin. J Pineal Res 2012; 52: 167-202.
9. Patki G, Lau YS,. Melatonin protects against neurobehavioral and mitochondrial deficits in a chronic mouse model of Parkinson's disease. Pharmacol Biochem Behav 2011; 99: 704-711.
10. Ochoa-Sanchez R, Comai S, Lacoste B, et al. Promotion of non-rapid eye movement sleep and activation of reticular thalamic neurons by a novel MT2 melatonin receptor ligand. J Neurosci 2011; 31: 18439-18452.
11. Liu C, Weaver DR, Jin X, et al. Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron 1997; 19: 91-102.
12. Reppert SM, Weaver DR, Rivkees SA, et al. Putative melatonin receptors in a human biological clock. Science 1988; 242: 78-81.
13. Weaver DR, Stehle JH, Stopa EG, et al. Melatonin receptors in human hypothalamus and pituitary: implications for circadian and reproductive responses to melatonin. J Clin Endocrinol Metab 1993; 76: 295-301.
14. Reppert SM, Godson C, Mahle CD, et al. Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Proc Natl Acad Sci U S A 1995; 92: 8734-8738.
15. Dubocovich ML, Yun K, Al-Ghoul WM, et al. Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms. FASEB J 1998; 12: 1211-1220.
16. Hunt AE, Al-Ghoul WM, Gillette MU, et al. Activation of MT(2) melatonin receptors in rat suprachiasmatic nucleus phase advances the circadian clock. Am J Physiol Cell Physiol 2001; 280: C110-C118.
17. Drew JE, Barrett P, Mercer JG, et al. Localization of the melatonin-related receptor in the rodent brain and peripheral tissues. J Neuroendocrinol 2001; 13: 453-458.
18. Savaskan E, Wirz-Justice A, Olivieri G, et al. Distribution of melatonin MT1 receptor immunoreactivity in human retina. J Histochem Cytochem 2002; 50: 519-526.
19. Savaskan E, Ayoub MA, Ravid R, et al. Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease. J Pineal Res 2005; 38: 10-16.
20. Angeloni D, Longhi R, Fraschini F,. Production and characterization of antibodies directed against the human melatonin receptors Mel-1a (mt1) and Mel-1b (MT2). Eur J Histochem 2000; 44: 199-204.
21. Nonno R, Lucini V, Pannacci M, et al. Pharmacological characterization of the human melatonin Mel1a receptor following stable transfection into NIH3T3 cells. Br J Pharmacol 1998; 124: 485-492.
22. Nonno R, Pannacci M, Lucini V, et al. Ligand efficacy and potency at recombinant human MT2 melatonin receptors: evidence for agonist activity of some mt1-antagonists. Br J Pharmacol 1999; 127: 1288-1294.
23. Lacoste B, Riad M, Descarries L,. Immunocytochemical evidence for the existence of substance P receptor (NK1) in serotonin neurons of rat and mouse dorsal raphe nucleus. Eur J Neurosci 2006; 23: 2947-2958.
24. Lacoste B, Riad M, Ratte MO, et al. Trafficking of neurokinin-1 receptors in serotonin neurons is controlled by substance P within the rat dorsal raphe nucleus. Eur J Neurosci 2009; 29: 2303-2314.
25. Berube-Carriere N, Guay G, Fortin GM, et al. Ultrastructural characterization of the mesostriatal dopamine innervation in mice, including two mouse lines of conditional VGLUT2 knockout in dopamine neurons. Eur J Neurosci 2012; 35: 527-538.
26. Aika Y, Ren JQ, Kosaka K, et al. Quantitative analysis of GABA-like-immunoreactive and parvalbumin-containing neurons in the CA1 region of the rat hippocampus using a stereological method, the disector. Exp Brain Res 1994; 99: 267-276.
27. Dubocovich ML, Delagrange P, Krause DN, et al. International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors. Pharmacol Rev 2010; 62: 343-380.
28. Vanecek J,. Melatonin binding sites. J Neurochem 1988; 51: 1436-1440.
29. Perreau-Lenz S, Kalsbeek A, Garidou ML, et al. Suprachiasmatic control of melatonin synthesis in rats: inhibitory and stimulatory mechanisms. Eur J Neurosci 2003; 17: 221-228.
30. Dubocovich ML, Rivera-Bermudez MA, Gerdin MJ, et al. Molecular pharmacology, regulation and function of mammalian melatonin receptors. Front Biosci 2003; 8: d1093-d1108.
31. Laitinen JT, Saavedra JM,. Characterization of melatonin receptors in the rat suprachiasmatic nuclei: modulation of affinity with cations and guanine nucleotides. Endocrinology 1990; 126: 2110-2115.
32. Williams LM, Morgan PJ,. Demonstration of melatonin-binding sites on the pars tuberalis of the rat. J Endocrinol 1988; 119: R1-R3.
33. Morgan PJ, Williams LM, Davidson G, et al. Melatonin receptors on ovine pars tuberalis: characterization and autoradiographicai localization. J Neuroendocrinol 1989; 1: 1-4.
34. Wu YH, Zhou JN, Balesar R, et al. Distribution of MT1 melatonin receptor immunoreactivity in the human hypothalamus and pituitary gland: colocalization of MT1 with vasopressin, oxytocin, and corticotropin-releasing hormone. J Comp Neurol 2006; 499: 897-910.
35. Gauer F, Masson-Pevet M, Pevet P,. Melatonin receptor density is regulated in rat pars tuberalis and suprachiasmatic nuclei by melatonin itself. Brain Res 1993; 602: 153-156.
36. Gauer F, Masson-Pevet M, Skene DJ, et al. Daily rhythms of melatonin binding sites in the rat pars tuberalis and suprachiasmatic nuclei; evidence for a regulation of melatonin receptors by melatonin itself. Neuroendocrinology 1993; 57: 120-126.
37. Weaver D, Rivkees S, Reppert S,. Localization and characterization of melatonin receptors in rodent brain by in vitro autoradiography. J Neurosci 1989; 9: 2581-2590.
38. Williams LM,. Melatonin-binding sites in the rat brain and pituitary mapped by in-vitro autoradiography. J Mol Endocrinol 1989; 3: 71-75.
39. Laudon M, Nir I, Zisapel N,. Melatonin receptors in discrete brain areas of the male rat. Impact of aging on density and on circadian rhythmicity. Neuroendocrinology 1988; 48: 577-583.
40. Williams LM, Hannah LT, Hastings MH, et al. Melatonin receptors in the rat brain and pituitary. J Pineal Res 1995; 19: 173-177.
41. Uz T, Arslan AD, Kurtuncu M, et al. The regional and cellular expression profile of the melatonin receptor MT1 in the central dopaminergic system. Brain Res Mol Brain Res 2005; 136: 45-53.
42. Ahn S-K, Khalmuratova R, Hah Y-S, et al. Immunohistochemical and biomolecular identification of melatonin 1a and 1b receptors in rat vestibular nuclei. Auris Nasus Larynx 2012; 39: 479-483.
43. Poirel VJ, Masson-Pevet M, Pevet P, et al. MT1 melatonin receptor mRNA expression exhibits a circadian variation in the rat suprachiasmatic nuclei. Brain Res 2002; 946: 64-71.
44. Mazzucchelli C, Pannacci M, Nonno R, et al. The melatonin receptor in the human brain: cloning experiments and distribution studies. Brain Res Mol Brain Res 1996; 39: 117-126.
45. Musshoff U, Riewenherm D, Berger E, et al. Melatonin receptors in rat hippocampus: molecular and functional investigations. Hippocampus 2002; 12: 165-173.
46. Stankov B, Cozzi B, Lucini V, et al. Characterization and mapping of melatonin receptors in the brain of three mammalian species: rabbit, horse and sheep. A comparative in vitro binding study. Neuroendocrinology 1991; 53: 214-221.
47. Reiter R, Tan D, Manchester L, et al. Medical implications of melatonin: receptor-mediated and receptor-independent actions. Adv Med Sci 2007; 52: 11-28.
48. Comai S, Ochoa-Sanchez R, Gobbi G,. Sleep-wake characterization of double MT(1)/MT(2) receptor knockout mice and comparison with MT(1) and MT(2) receptor knockout mice. Behav Brain Res 2013; 243: 231-238.
49. Clement O, Sapin E, Libourel PA, et al. The lateral hypothalamic area controls paradoxical (REM) sleep by means of descending projections to brainstem GABAergic neurons. J Neurosci 2012; 32: 16763-16774.
50. Hepp K, Henn V,. Spatio-temporal recoding of rapid eye movement signals in the monkey paramedian pontine reticular formation (PPRF). Exp Brain Res 1983; 52: 105-120.
51. Lindroos O, Veilahti J, Leinonen L, et al. Characterization of melatonin binding to the anteroventral and anterodorsal thalamic nuclei of the rat. Eur J Pharmacol 1993; 250: 161-163.
52. Dominguez-Lopez S, Howell R, Gobbi G,. Characterization of serotonin neurotransmission in knockout mice: implications for major depression. Rev Neurosci 2012; 23: 429-443.
53. Comai S, Ochoa-Sanchez R, Dominguez-Lopez S, et al. Melancholic-like behaviors and circadian neurobiological abnormalities in melatonin MT1 receptor knockout mice. Int J Neuropsychopharmacol 2015; 18: 1-10.
54. Dominguez-Lopez S, Mahar I, Bambico FR, et al. Short-term effects of melatonin and pinealectomy on serotonergic neuronal activity across the light-dark cycle. J Psychopharmacol 2012; 26: 830-844.
55. Malpaux B, Daveau A, Maurice-Mandon F, et al. Evidence that melatonin acts in the premammillary hypothalamic area to control reproduction in the ewe: presence of binding sites and stimulation of luteinizing hormone secretion by in situ microimplant delivery. Endocrinology 1998; 139: 1508-1516.
56. Silman R,. Melatonin and the human gonadotrophin-releasing hormone pulse generator. J Endocrinol 1991; 128: 7-11.
57. Olcese J, Lozier S, Paradise C,. Melatonin and the circadian timing of human parturition. Reprod Sci 2013; 20: 168-174.
58. Savaskan E, Olivieri G, Meier F, et al. Increased melatonin 1a-receptor immunoreactivity in the hippocampus of Alzheimer's disease patients. J Pineal Res 2002; 32: 59-62.
59. Brunner P, Sozer-Topcular N, Jockers R, et al. Pineal and cortical melatonin receptors MT1 and MT2 are decreased in Alzheimer's disease. Eur J Histochem 2006; 50: 311-316.
60. Dominguez-Lopez S, Howell RD, Lopez-Canul MG, et al. Electrophysiological characterization of dopamine neuronal activity in the ventral tegmental area across the light-dark cycle. Synapse 2014; 68: 454-467.
61. Sircar R,. Effect of melatonin on cocaine-induced behavioral sensitization. Brain Res 2000; 857: 295-299.
62. Exposito I, Mora F, Zisapel N, et al. The modulatory effect of melatonin on the dopamine-glutamate interaction in the anterior hypothalamus during ageing. NeuroReport 1995; 6: 2399-2403.
63. Adi N, Mash DC, Ali Y, et al. Melatonin MT1 and MT2 receptor expression in Parkinson's disease. Med Sci Monit 2010; 16: BR61-BR67.
64. Sumaya IC, Byers DM, Irwin LN, et al. Circadian-dependent effect of melatonin on dopaminergic D2 antagonist-induced hypokinesia and agonist-induced stereotypies in rats. Pharmacol Biochem Behav 2004; 78: 727-733.
65. Pazo JH,. Effects of melatonin on spontaneous and evoked neuronal activity in the mesencephalic reticular formation. Brain Res Bull 1979; 4: 725-730.
66. Castillo Romero JL, Vives Montero F, Acuna Castroviejo D,. Paradoxical effects of melatonin on spontaneous neuronal activity in the striatum of sham-operated and pinealectomized rats. J Pineal Res 1992; 12: 149-154.
67. Naranjo-Rodriguez EB, Prieto-Gomez B, Reyes-Vazquez C,. Melatonin modifies the spontaneous multiunit activity recorded in several brain nuclei of freely behaving rats. Brain Res Bull 1991; 27: 595-600.
68. Mason R, Brooks A,. The electrophysiological effects of melatonin and a putative melatonin antagonist (N-acetyltryptamine) on rat suprachiasmatic neurones in vitro. Neurosci Lett 1988; 95: 296-301.
69. Ambriz-Tututi M, Rocha-Gonzalez HI, Cruz SL, et al. Melatonin: a hormone that modulates pain. Life Sci 2009; 84: 489-498.
70. Lopez-Canul M, Palazzo E, Dominguez-Lopez S, et al. Selective melatonin MT2 receptor ligands relieve neuropathic pain through modulation of brainstem descending antinociceptive pathways. Pain 2015; 156: 305-317.
71. Hahm ET, Kim Y, Lee JJ, et al. GABAergic synaptic response and its opioidergic modulation in periaqueductal gray neurons of rats with neuropathic pain. BMC Neurosci 2011; 12: 41.
72. Yadin E, Thomas E, Grishkat HL, et al. The role of the lateral septum in anxiolysis. Physiol Behav 1993; 53: 1077-1083.
73. Karakas A, Coskun H, Kaya A, et al. The effects of the intraamygdalar melatonin injections on the anxiety like behavior and the spatial memory performance in male Wistar rats. Behav Brain Res 2011; 222: 141-150.
74. Ochoa-Sanchez R, Rainer Q, Comai S, et al. Anxiolytic effects of the melatonin MT(2) receptor partial agonist UCM765: comparison with melatonin and diazepam. Prog Neuropsychopharmacol Biol Psychiatry 2012; 39: 318-325.
75. Jin X, Von Gall C, Pieschl RL, et al. Targeted disruption of the mouse Mel(1b) melatonin receptor. Mol Cell Biol 2003; 23: 1054-1060.
76. Paxinos G, Watson C,. The Rat Brain in Stereotaxic Coordinates: Compact. 6th edn. Academic Press, London, 2009.